A method for extracting and preparing high-purity golden amide alcohol acetate from the whole herb of Polygonum capitatum and its application
High-purity acetic acid acetate was prepared from Polygonum multiflorum by heating reflux extraction with petroleum ether and forward silica gel column chromatography. The problem of extraction was solved and it was found that its inhibitory effect on human gastric cancer cells was achieved, achieving efficient anti-tumor Effect.
Patent Information
- Application Number
- CN202310447476.9
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- Filing Date
- 2023-04-24
- Publication Date
- 2024-11-15
- Estimated Expiration
- 2043-04-24
AI Technical Summary
At present, there is a lack of a method for extracting high-purity auricamide acetate from Polygonum multiflorum, and its inhibitory effect on the proliferation of BGC-823 cells in human gastric cancer and its related mechanisms have not been reported in literature.
The acetic amide alcohol acetate flow extract was prepared by petroleum ether heating reflux extraction method, and then eluted and purified by forward silica gel column chromatography. Combined with the use of ethyl acetate, a high purity of more than 98% acetic amide alcohol acetate was obtained. and explore its inhibitory effect on human gastric cancer cells.
It has successfully expanded the new source of aceticamide acetate, which is simple and low-cost extraction method, and has scientifically proved that it has significant anti-tumor activity, mainly by increasing the expression of pro-apoptotic-related proteins to change the cell cycle and promote cell apoptosis.
Smart Images

Figure CN116535330B_ABST
Abstract
Description
Technical Field
[0001] The invention relates to the field of medical technology, and in particular to a method for extracting and preparing high-purity golden amide alcohol acetate from the whole herb of Polygonum capitatum and its application. Background Art
[0002] Malignant tumors are an important factor that hinders the extension of human life expectancy and causes serious social burden [Liu Zongchao, Li Zhexuan, Zhang Yang, et al. Interpretation of the 2020 Global Cancer Statistics Report. Electronic Journal of Comprehensive Oncology Treatment, 2021, 7(2): 1-13. XiaCF, Dong XS, Li H, et al. Cancer statistics in China and United States, 2022: profiles, trends, and determinants. Chinese Medical Journal, 2022, 135(5): 584-590.]. In recent years, tumor resistance to multiple chemotherapeutic drugs and targeted drugs has increasingly become a major problem in tumor treatment [EsfahaniK, ElkriefA, CalabraseC, et al. Moving towards personalized treatments of immune-related adverse events. Nature Reviews Clinical Oncology, 2020, 17(8): 504-515.]. Chemical components such as vincristine, paclitaxel, camptothecin and podophyllotoxin extracted and isolated from medicinal plants have been proven to have significant anti-tumor activity and have been widely used in clinical treatment [Chen FQ, Li JQ, Wang H, et al. Anti-tumor effects of Chinese medicine compounds by regulating immune cells in microenvironment. Frontiers in Oncology, 2021, 11: 746917.].
[0003] Aurantiamide acetate, also known as orange-yellow piperonamide acetate, belongs to the dipeptide compound [Fang ZY, Fang J, Gao CX, et al. Aurantiamide acetate ameliorates lung inflammation in lipopolysaccharide-induced acute lung jury in mice. Biomed Research International, 2022, 2022: 3510423.], and its molecular structure is shown in the figure below.
[0004]
[0005] Aurantiamide acetate was originally isolated from the kernel of Piperwallichii (Miq.) Hand.-Mazz. (also known as golden pepper P. aurantiamide cum Wall.) of the Piperaceae family [Banerji A, Das R. Aurantiamide & aurantiamide acetate: new amides from Piperaurantiacum wall. Indian Journal of Chemistry Section B, 1975, 13: 1234-1236. Banerji A, Ray R. Aurantiamides: A new class of modified dipeptides from Piperaurantiacum. Phytochemistry, 1981, 20 (9): 2217-2220.], and was also isolated from Clematis terniflora, Portulaca oleracea, Baphica canthus cusia), and has many pharmacological activities such as antibacterial, antiviral, anti-inflammatory, and analgesic. However, due to the relatively complex chemical structure and low polarity of golden amide alcohol acetate, it is not easy to extract, separate, and purify from plants. Therefore, current researchers have conducted little in-depth research on the effects of golden amide alcohol acetate on the proliferation and apoptosis of other tumor cells and its mechanism of action.
[0006] Polygonum capitatum, also known as Four Seasons Red, Stone Mangcao, Water Hydrangea, Red Sour Rod, is a perennial herbaceous plant of the genus Polygonum of the Polygonaceae family. It is mainly produced in Jiangxi, Hunan, Hubei, Sichuan, Guizhou and other places in my country [Editorial Committee of Flora of China, Chinese Academy of Sciences. Flora of China (Volume 25, Part 1). Beijing: Science Press, 1998: 57-58.]. The whole plant is used as medicine, with a bitter and pungent taste and a cool nature. It has the effects of clearing away heat and dampness, detoxifying and relieving pain, harmonizing blood and removing blood stasis, and promoting diuresis and relieving stranguria [Nanjing University of Chinese Medicine. Chinese Medicine Dictionary (2nd Edition, Volume 1). Shanghai: Shanghai Science and Technology Press, 2006: 850-850. Guizhou Provincial Drug Administration. Quality Standards for Chinese Medicinal Materials and Ethnic Medicinal Materials in Guizhou Province (1st Edition). Guiyang: Guizhou Science and Technology Press, 2003: 147-147.]. Its chemical components are mainly volatile oils, lignans, flavonoids and phenolic acid compounds [Yang Y, Hong Q, Zhu B, et al. Polygonum capitatum Buch.-Ham. ex D. Don: A review of its phytochemistry. Food Science and Technology, 2022, 42: e110021.]. It has been reported in the literature that the polyphenol compound davidiin in Polygonum capitatum has anti-tumor activity and can inhibit the growth of human hepatocellular carcinoma cell lines [Wang Y, Ma JY, Chow SC, et al. A potential antitumor elaginitin, davidiin, inhibited hepatocellular tumor growth by targeting EZH2. Tumor Biology, 2014, 35: 205-212.]; Polygonum capitatum extract solution (concentration above 128 μg / mL) has a significant inhibitory effect on the growth of logarithmic phase GES-1 cells [Wen Lina, Luo Zhaoxun, Zhang Shu, et al. Study on the cytotoxicity of Polygonum capitatum on gastric mucosal epithelial cells GES-1. Guizhou Medicine, 2014, 38(10): 878-880.].
[0007] At present, there is no report in domestic or foreign literature on the method of extracting and preparing high-purity auramide acetate from Polygonum capitatum, and there is no report in domestic or foreign literature on the inhibitory effect of auramide acetate on the proliferation of human gastric cancer BGC-823 cells and its related mechanism. Summary of the invention
[0008] The present invention provides a method and application for extracting and preparing high-purity golden amide alcohol acetate from the whole herb of Polygonum capitatum, discovers for the first time that Polygonum capitatum contains golden amide alcohol acetate and provides an extraction and preparation method thereof, enriches the chemical component database of Polygonum capitatum, and discovers for the first time that golden amide alcohol acetate has a new medical use of inhibiting the proliferation of human gastric cancer BGC-823 cells.
[0009] The technical solution of the present invention includes the following contents: A method for extracting and preparing high-purity golden amide alcohol acetate from the whole herb of Polygonum capitatum, comprising the following steps:
[0010] 1) Preparation of golden amide alcohol acetate fluid extract: Cut the dried whole herb of Polygonum capitatum into coarse segments, extract with 5 times the volume of petroleum ether under heating and reflux for 3 times, and recover the solvent from the extract under reduced pressure to obtain golden amide alcohol acetate fluid extract;
[0011] 2) Preparing a crude extract of golden amide alcohol acetate: taking the golden amide alcohol acetate fluid extract, performing normal silica gel column chromatography, first eluting the golden amide alcohol acetate fluid extract with a mixture of petroleum ether and ethyl acetate in a volume ratio of 3:1, and discarding the eluent; then eluting the golden amide alcohol acetate fluid extract with a mixture of petroleum ether and ethyl acetate in a volume ratio of 2:1, recovering the solvent from the eluent under reduced pressure and evaporating to dryness, to obtain a crude extract of golden amide alcohol acetate;
[0012] 3) Preparation of high-purity golden amide alcohol acetate: Take the above-mentioned golden amide alcohol acetate crude extract, dissolve it with petroleum ether, then add ethyl acetate dropwise, let it stand, precipitate a light yellow powder, and then wash it with petroleum ether to obtain a white powder with a purity greater than 98% of golden amide alcohol acetate.
[0013] In some embodiments, in step 1), the extract is decompressed at a temperature not exceeding 65°C to recover the solvent; in step 2), the eluent is decompressed at a temperature not exceeding 65°C to recover the solvent.
[0014] In some embodiments, in step 2), the column chromatography silica gel used is 100-200 mesh; the amount of silica gel used is 10 times the mass of the sample loaded on the column.
[0015] In some embodiments, in step 3), the mass volume ratio of petroleum ether used for dissolution treatment to the crude extract of golden amide alcohol acetate is 1 mL: 1 g;
[0016] The volume ratio of ethyl acetate added before standing for precipitation to petroleum ether used for dissolution treatment is 1:10;
[0017] The volume ratio of petroleum ether used in the cleaning treatment to that used in the dissolving treatment is 1:10.
[0018] The present invention also provides the use of the golden amide alcohol acetate in the preparation of the anti-gastric cancer BGC-823 drug.
[0019] The beneficial effects of the present invention are as follows: 1. An innovative method for extracting and preparing golden amide alcohol acetate with a purity greater than 98% from Polygonum capitatum is invented, thereby expanding the new source of golden amide alcohol acetate;
[0020] 2. During the extraction and preparation, only positive silica gel is used as the chromatographic filler, and only petroleum ether and ethyl acetate are used as organic reagents. The operation is relatively simple, low-cost, non-toxic and environmentally friendly, and the method is easy to promote;
[0021] 3. For the first time, it was discovered that golden amide alcohol acetate has a new medical use of inhibiting the proliferation of human gastric cancer BGC-823 cells; the in vitro anti-tumor activity of golden amide alcohol acetate was scientifically confirmed, and it was found that its anti-tumor mechanism was mainly related to changing the cell cycle and promoting cell apoptosis by increasing the expression of pro-apoptotic related proteins. BRIEF DESCRIPTION OF THE DRAWINGS
[0022] Figure 1 The mass spectrum (MS) of the golden amide alcohol acetate extracted and prepared by the present invention;
[0023] Figure 2 This is the nuclear magnetic resonance hydrogen spectrum of the golden amide alcohol acetate extracted and prepared by the present invention ( 1 H-NMR);
[0024] Figure 3 This is the carbon NMR spectrum of the golden amide alcohol acetate extracted and prepared by the present invention ( 13 C-NMR);
[0025] Figure 4 The ultraviolet spectrum (UV) of the golden amide alcohol acetate extracted and prepared by the present invention;
[0026] Figure 5 The high performance liquid chromatogram (HPLC) of the golden amide alcohol acetate extracted and prepared by the present invention (in the figure, 1. golden amide alcohol acetate);
[0027] Figure 6 The inhibitory effect of the golden amide alcohol acetate extracted and prepared by the present invention on the proliferation of HUVECs cells at different culture times;
[0028] Figure 7 The inhibitory effect of the golden amide alcohol acetate extracted and prepared by the present invention on the proliferation of different tumor cells after 48 hours of culture (Figure, Compared with the 0μmol / L group, * P<0.05, ** P<0.01, *** P < 0.001, **** P<0.0001);
[0029] Figure 8 The inhibitory effect of the golden amide alcohol acetate extracted and prepared by the present invention on the proliferation of BGC-823 cells at different culture times (Figure, Compared with the 0μmol / L group, **** P<0.0001);
[0030] Fig. 9 The effect of the golden amide alcohol acetate extracted and prepared by the present invention on the morphology of BGC-823 cells;
[0031] Fig.10 The effect of the golden amide alcohol acetate extracted and prepared by the present invention on apoptosis of BGC-823 cells (Figure, a. Apoptosis of BGC-823 cells; b. Annexin V / PI staining flow cytometry; compared with the 0μmol / L group, * P<0.05, *** P<0.001);
[0032] Fig.11 This is a flow cytometric graph showing the effect of the golden amide alcohol acetate extracted and prepared by the present invention on the cell cycle of BGC-823 cells;
[0033] Fig.12 The effect of the golden amide alcohol acetate extracted and prepared by the present invention on the protein expression of BGC-823 cells (Figure, a. Bax protein blot; b. Bax protein expression; c. caspase-3 protein blot; d. caspase-3 protein expression; compared with the 0 μmol / L group, * P<0.05, ** P<0.01, *** P<0.001). DETAILED DESCRIPTION
[0034] The present invention will be further described below in conjunction with the embodiments.
[0035] Example 1: Extraction, preparation and purity testing of golden amide alcohol acetate in Polygonum capitatum
[0036] 1 Materials
[0037] 1.1 Instruments Quintix 224-1CN electronic analytical balance, manufactured by Sartorius, Germany. MAT-212 fast atom bombardment mass spectrometer, manufactured by Varian, USA. Avance III 600HD superconducting Fourier nuclear magnetic resonance spectrometer, manufactured by Bruker BioSpin, Switzerland. N-1100 rotary evaporator, manufactured by Eyela, Japan. Agilent 1260 high performance liquid chromatography system (including DAD detector), manufactured by Agilent, USA.
[0038] 1.2 Drugs The medicinal material Polygonum capitatum Buch.-Ham. ex D. Don was purchased from Shibing County, Guizhou Province in September 2015 and identified by Professor Wu Zhijun of the Pharmacy Department of Changzheng Hospital Affiliated to Naval Medical University as the dried whole herb of Polygonum capitatum Buch.-Ham. ex D. Don of the Polygonaceae family. The specimens are stored in the specimen room of the Pharmacy Department of Changzheng Hospital.
[0039] 1.3 Reagents Column chromatography silica gel (100-200 mesh) and thin layer chromatography silica gel plates (HSGF254) were purchased from Yantai Jiangyou Silica Gel Development Company (batch number 20140610). Water was purified water, and the other organic reagents were of analytical grade.
[0040] 2 Methods
[0041] 2.1 Extraction and preparation Weigh 2 kg of dried whole herb of Polygonum capitatum, cut into coarse sections, use 5 times the volume of petroleum ether (60°C-90°C) to heat and reflux for extraction 3 times, and recover the solvent under reduced pressure (temperature 60°C) to obtain 30 g of golden amide alcohol acetate fluid extract; after dissolving with a small amount of ethyl acetate, add 45 g of silica gel (100-200 mesh) to mix the sample, evaporate the solvent, and perform normal silica gel column chromatography (chromatographic column diameter 5 cm, silica gel dosage 300 g), first use a mixture of petroleum ether and ethyl acetate in a volume ratio of 3:1 to elute the golden amide alcohol acetate fluid extract, and discard the eluent; then use a mixture of petroleum ether and ethyl acetate in a volume ratio of 2:1 to elute the golden amide alcohol acetate fluid extract. The golden amide alcohol acetate fluid extract was eluted, and the eluent was evaporated to dryness after recovering the solvent under reduced pressure (temperature 60°C) to obtain a crude extract of golden amide alcohol acetate; the crude extract was dissolved in an appropriate amount of petroleum ether (the mass volume ratio of petroleum ether used for dissolution treatment to the crude extract of golden amide alcohol acetate was 1 mL:1 g); an appropriate amount of ethyl acetate was added dropwise (the volume ratio of ethyl acetate added before standing and precipitation to the petroleum ether used for dissolution treatment was 1:10), and after standing, a light yellow powder was precipitated; it was then washed with an appropriate amount of petroleum ether (the volume ratio of petroleum ether used for washing treatment to petroleum ether used for dissolution treatment was 1:10) to obtain a white powdery compound (30 mg, batch number AA202112).
[0042] 2.2 Structural identification Comprehensive application of a variety of physical and chemical methods, ultraviolet (UV), mass spectrometry (MS), nuclear magnetic resonance spectroscopy ( 1 H-NMR), carbon nuclear magnetic resonance spectroscopy ( 13 C-NMR) and other modern spectral analysis techniques were used to identify the structure of the compound powder.
[0043] 2.3 Purity detection The purity of the golden amide alcohol acetate powder was detected by high performance liquid chromatography (peak area normalization method). The chromatographic analysis conditions were: the chromatographic column was Diamonsil C 18 (2) Column (5μ, 250 mm × 4.6 mm), mobile phase was methanol-water (90:10), isocratic elution, detection wavelength was 230 nm, column temperature was 35 °C, and flow rate was 1.0 mL / min.
[0044] 3 Results
[0045] 3.1 Physical and chemical properties White powder, easily soluble in chloroform, methanol and other solvents.
[0046] 3.2 Structural identification results ESI-MS: m / z 445.2 [M+H] + , 443.2[MH] - ; Molecular formula is C 27 H 28 N2O4, molecular weight is 444.2. Mass spectrum (MS) see Figure 1 .
[0047] 1H-NMR (600MHz, CDCl3), δ: 7.75 (2H, d, J=7.8Hz, H-2″, H-6″), 7.54 (1H, t, J=7.2Hz, H-4″), 7.44 (2H, d, J=7.2Hz, H-3″, H-5″), 7.28 (4H, m, H-3, H-5, H- 3′, H-5′), 7.24 (1H, m, H-4), 7.18 (2H, m, H-2, H-6), 7.14 (1H, m, H-4′), 7.0 9(2H,m,H-2′,H-6′), 7.07(1H,m,N′-H), 6.56(1H,d,J=8.4Hz,NH), 4.93(1 H, q, J = 7.2 Hz, H-8′), 4.39 (1H, dddd, J = 4.2, 4.8, 6.6, 7.8 Hz, H-8), 3.95 (1H, dd, J = 4.8, 11.4 Hz, H-9), 3.90 (1H, dd, J = 4.2, 11.4 Hz, H-9), 3.26 (1H, dd, J = 6.6, 13.2 Hz, H-7′), 3.15 (1H, dd, J = 7.8, 13.2 Hz, H-7′), 2.80 (1H, dd, J = 6.6, 13.8 Hz, H-7), 2.75 (1H, dd, J = 7.8, 13.8 Hz, H-7), 2.04 (3H, s, H-7″). H NMR spectrum ( 1 H-NMR) Figure 2 .
[0048] 13 C-NMR (150MHz, CDCl3) δ: 170.7(C-1″′), 170.5(C-9′), 167.1(C-7″), 136.7(C-1), 136.6 (C-1′), 133.6(C-1″), 131.8(C-4″), 129.3(C-3, C-5), 129.0(C-2′, C-6′), 128.6(C-3″, C -5″), 128.5 (C-2, C-6), 128.5 (C-3′, C-5′), 127.1 (C-2″, C-6″), 127.0 (C-4), 126.6 (C-4′), 64.5 (C-9), 54.9 (C-8′), 49.4 (C-8), 38.5 (C-7′), 37.4 (C-7), 20.7 (C-2″′). Carbon NMR spectrum ( 13 C-NMR) Figure 3 .
[0049] Above MS, 1 H-NMR, 13The C-NMR data were basically consistent with those reported in the literature [Yoon CS, Kim DC, Lee DS, et al. Anti-neuroinflammatory effect of aurantiamide acetate from the marine fungus Aspergillus sp. SF-5921: Inhibition of NF-κB and MAPK pathways in lipopolysaccharide-induced mouse BV2 microglial cells. International Journal of Immunopharmacology, 2014, 23: 568-574.], and the compound powder was identified as aurantiamide acetate, which was isolated from the species of Polygonum capitatum for the first time.
[0050] 3.3 Purity test results The purity of the golden amide alcohol acetate in the powder was 98.21%. Its ultraviolet spectrum (UV) is shown in Figure 4 , high performance liquid chromatogram (HPLC) see Figure 5 .
[0051] Example 2: In vitro antitumor activity study of golden amide alcohol acetate
[0052] 1 Materials
[0053] 1.1 Instruments Quintix 224-1CN electronic analytical balance, a product of Sartorius, Germany. 4011-A2 biological safety cabinet, a product of Qingdao Haier Co., Ltd. HF240 carbon dioxide constant temperature incubator, a product of Shanghai Lishen Scientific Instrument Co., Ltd. TE2000-S inverted microscope, a product of Nikon, Japan. ST-360 microplate reader, a product of Shanghai Kehua Experimental System Co., Ltd. LSRⅡ flow cytometer, a product of BD, USA. Trans-Blot SD semi-dry Western-blotting transfer instrument, a product of Bio-Rad Laboratories, USA. DYY-6C electrophoresis instrument, a product of Beijing Liuyi Biotechnology Co., Ltd.
[0054] 1.2 Drug aurantiamide acetate, produced by our research group, batch number AA202112, purity of 98.21% (peak area normalization method HPLC purity detection).
[0055] 1.3 Reagents BD FITC Annexin V apoptosis detection kit was purchased from BD, USA, batch number 1271578. Cell cycle analysis kit was purchased from Suzhou Yueya Company, batch number 20211231. Trypsin was purchased from Sigma, USA, batch number 110M7362V. CCK-8 kit, Bcl-2associated X protein (Bax) antibody, and cysteinyl aspartate specific proteinase-3 (caspase-3) antibody were all purchased from Shanghai Biyuntian Biotechnology Co., Ltd., batch numbers 112921220128, 071122220818, and 030722220930, respectively. RPMI-1640 medium, DMEM medium and fetal bovine serum were purchased from Gibco, USA, with batch numbers 8122046, 8121641 and 2372879P, respectively. Water was purified water, and the other reagents were of analytical grade.
[0056] 1.4 Cell lines Human gastric cancer BGC-823 cells were purchased from the Shanghai Institute of Cell Biology, Chinese Academy of Sciences; human lung cancer A549 cells were donated by the Laboratory of Oncology, Changzheng Hospital, Naval Medical University; colorectal cancer Caco-2 cells were purchased from Shanghai Jichun Industrial Co., Ltd.; human umbilical vein endothelial cells (HUVECs) were purchased from Hangzhou Huixing Biotechnology Co., Ltd.
[0057] 2 Methods
[0058] 2.1 Cell Culture HUVECs cells and colorectal cancer Caco-2 cells were cultured in DMEM medium containing 10% fetal bovine serum, gastric cancer BGC-823 cells and lung cancer A549 cells were cultured in RPMI-1640 medium containing 10% fetal bovine serum in a constant temperature incubator at 37°C and 5% (volume fraction) CO2. The medium was changed every 1-2 days according to the cell growth. When the cell density exceeded 80%, the cells were passaged and the cells in the logarithmic growth phase were used for subsequent experiments.
[0059] 2.2 Solution Preparation Weigh 4.44 mg of golden amide alcohol acetate powder accurately, dissolve it in 1 mL of dimethyl sulfoxide (DMSO), prepare a mother solution with a concentration of 10 μmol / mL, filter it through a 0.22 μm microporous filter membrane, dispense it into 100 μL plastic centrifuge tubes, and store it in a -80°C refrigerator. According to the preliminary experimental results, add the culture medium solution to dilute the mother solution into (0, 12.5, 25, 50, 100) μmol / L sample solutions before use.
[0060] 2.3 Experiment on inhibition of cell proliferation HUVECs cells, gastric cancer BGC-823 cells, lung cancer A549 cells, and colorectal cancer Caco-2 cells were passaged twice and the cell concentration in the logarithmic growth phase was adjusted to 1×10 4 / mL, inoculated into 96-well cell culture plates, added with gold amide alcohol acetate solution with final concentrations of (0, 12.5, 25, 50, 100) μmol / L, and made 3 duplicate wells for each group. After culturing in a CO2 incubator for 24 or 48 hours, 20 μL of CCK-8 reagent was added to each well, and the culture was continued for 2 hours. The absorbance (OD) value was detected at a wavelength of 450nm on an ELISA reader. The cell proliferation inhibition rate was calculated as follows: Cell proliferation inhibition rate (%) = (OD 对照组 -OD 药物组 ) / (OD 对照组 ) × 100%. The experiment was repeated three times independently.
[0061] 2.4 Effect on BGC-823 Cell Morphology According to the results of CCK-8 experiment, three concentration gradients of golden amide alcohol acetate solution were selected, 25 μmol / L, 50 μmol / L, and 100 μmol / L, and co-cultured with BGC-823 cells for 48 h for the next experiment. BGC-823 cells in logarithmic growth were taken and digested with trypsin, and the cell concentration was adjusted to 1×10 5 / mL, inoculated in a 6-well plate, 4 mL per well, cultured for 24 h, added with a golden amide acetate solution at a concentration of (0, 25, 50, 100) μmol / L, and cultured for 48 h before observing the cell morphology under an inverted microscope and taking photos.
[0062] 2.5 Experiment on the effect on apoptosis of BGC-823 cells Cells were cultured for 48 h according to the above-mentioned cell morphology effect experimental method, and the cells were digested and collected using trypsin, and the cells were washed twice with phosphate buffer solution (PBS) to prepare a cell suspension. 1× binding buffer was added to suspend the cells, and Annexin V-FITC and propidium iodide (PI) solution were added for staining according to the instructions, incubated at room temperature in the dark for 15 min, and detected and analyzed using a flow cytometer. The experiment was repeated 3 times independently.
[0063] 2.6 Experiment on the effect on BGC-823 cell cycle According to the above cell morphology effect experimental method, cells were cultured for 48 hours, collected, washed, and resuspended. According to the instructions, 100 μL of reagent A (trypsin) was added in sequence, and it was placed at room temperature for 10 minutes. 100 μL of reagent B (RNA enzyme, trypsin inhibitor, etc.) was added, and it was placed at room temperature for 10 minutes. 150 μL of reagent C (PI) was added, and it was placed at room temperature for 15 minutes. Cell detection was performed using a flow cytometer, and the results were analyzed using FlowJo 10.8 software. The experiment was repeated 3 times independently.
[0064] 2.7 Experiment on the effect of pro-apoptotic protein expression Cells were cultured for 48 h according to the above-mentioned cell morphology effect experimental method, and the cells were digested and collected using trypsin, washed with 1 mL to 2 mL PBS, and prepared into a cell suspension. The collected cells were added with IP protein lysis buffer containing phenylmethylsulfonyl chloride (PMSF) and lysed on ice for 30 min. The protein supernatant was collected after centrifugation at 4 °C. The protein concentration of each group of samples was determined by bicinchoninic acid (BCA) protein quantification method. Each group of samples was subjected to electrophoresis, transfer, blocking with QuickBlock TM blocking buffer (TBSTx), incubation with primary and secondary antibodies, color development with BCIP / NBT staining working solution, and washing with distilled water 1 to 2 times to terminate the color development reaction. The expression of pro-apoptotic related proteins Bax and caspase-3 was detected by Western blot method, and Western blot image analysis was performed using Image J 1.53 software. The experiment was repeated 3 times independently.
[0065] 2.8 Statistical analysis Experimental data are presented as mean ± standard deviation GraphPad Prism 8.0 software was used to draw bar graphs and line graphs, and SPSS Statistics 21.0 software was used for data processing. One-way analysis of variance was used for comparison between groups, and Dunnett-t test was used for pairwise comparison between groups. The test level was α=0.05, and P<0.05 was considered statistically significant.
[0066] 3 Results
[0067] 3.1 Results of the cell proliferation inhibition experiment After 24h and 48h of culture, the golden amide alcohol acetate groups had no inhibitory effect on HUVECs cell proliferation (P>0.05). Figure 6 .
[0068] After 48 h of culture, aureamide acetate had the most significant inhibitory activity on the proliferation of BGC-823 cells. Compared with the 0 μmol / L group, the inhibition rates of 12.5 μmol / L, 25 μmol / L, 50 μmol / L, and 100 μmol / L aureamide acetate groups on the proliferation of BGC-823 cells were significantly increased (all P<0.0001). 50 Compared with the 0μmol / L group, the inhibition rates of A549 cell proliferation in the 25μmol / L, 50μmol / L, and 100μmol / L groups were significantly increased (P<0.05, P<0.01, and P<0.0001, respectively); compared with the 0μmol / L group, the inhibition rates of Caco-2 cell proliferation in the 12.5μmol / L, 25μmol / L, 50μmol / L, and 100μmol / L groups were significantly increased (P<0.05, P<0.05, P<0.001, and P<0.0001, respectively). Figure 7 .
[0069] After 24h and 48h of culture, compared with the 0μmol / L group, the inhibition rate of BGC-823 cell proliferation in the 12.5μmol / L, 25μmol / L, 50μmol / L, and 100μmol / L auramide acetate groups was significantly increased (all P<0.0001). In the concentration range of 25μmol / L to 100μmol / L, the inhibition of cell proliferation showed a time- and dose-dependent effect relationship. Figure 8 .
[0070] 3.2 Results of the experiment on cell morphology After 48 hours of culture, the growth state of BGC-823 cells in the 0μmol / L group was better, with a fusiform and other polygonal morphology, firm adhesion to the wall, and high density; BGC-823 cells in the 25μmol / L, 50μmol / L, and 100μmol / L golden amide alcohol acetate groups became rounder and smaller, with concentrated nuclei, lower cell density, loose adhesion to the wall, and floating cells, with apoptotic bodies around them, showing obvious apoptotic characteristics, and the apoptotic characteristics of cells in the 100μmol / L group were the most obvious. Results are shown in Fig. 9 .
[0071] 3.3 Results of the cell apoptosis experiment After 48 hours of culture, compared with the 0μmol / L group, the apoptosis rate of BGC-823 cells in the 50μmol / L and 100μmol / L auramide acetate groups was significantly increased (P<0.05, P<0.001, respectively), and the effect was dose-dependent. The experiment showed that auramide acetate can inhibit the proliferation of BGC-823 cells by inducing cell apoptosis. The results are shown in Fig.10 .
[0072] 3.4 Results of the cell cycle effect experiment After 48 hours of culture, compared with the 0μmol / L group, the proportion of G0 / G1 phase cells of BGC-823 cells in the 100μmol / L golden amide alcohol acetate group was significantly reduced (P<0.01); the proportion of S phase cells of BGC-823 cells in the 25μmol / L, 50μmol / L, and 100μmol / L groups was extremely significantly reduced (all P<0.0001), and the proportion of G2 / M phase cells was extremely significantly increased (all P<0.0001). The experiment showed that golden amide alcohol acetate mainly blocked cells in the G2 / M phase and induced apoptosis of BGC-823 cells. The results are shown in Table 1. Fig.11 .
[0073] Table 1 Effect of aureoacetate on the cell cycle of BGC-823 cells
[0074]
[0075] Note: Compared with the 0μmol / L group, ** P<0.01, **** P<0.0001
[0076] 3.5 Protein expression effect experimental results After 48 hours of culture, compared with the 0μmol / L group, with the increase of the concentration of golden amide alcohol acetate, the expression ratio of caspase-3 and Bax to Tublin protein was significantly higher than that of the control group, and the difference was statistically significant (P<0.05). The experiment showed that golden amide alcohol acetate promoted cell apoptosis, which may be related to the upregulation of the expression of pro-apoptotic proteins caspase-3 and Bax. The results are shown in Fig.12 .
Claims
1. A method for extracting and preparing high-purity golden amide alcohol acetate from the whole herb of Polygonum capitatum, characterized in that: The steps include: 1) Preparation of golden amide alcohol acetate fluid extract: Cut the dried whole herb of Polygonum capitatum into coarse segments, use 5 times the volume of petroleum ether to heat and reflux for extraction 3 times, and recover the solvent from the extract under reduced pressure to obtain golden amide alcohol acetate fluid extract; 2) Preparing a crude extract of golden amide alcohol acetate: taking the golden amide alcohol acetate fluid extract, performing normal silica gel column chromatography, first eluting the golden amide alcohol acetate fluid extract with a mixture of petroleum ether and ethyl acetate in a volume ratio of 3:1, and discarding the eluent; then eluting the golden amide alcohol acetate fluid extract with a mixture of petroleum ether and ethyl acetate in a volume ratio of 2:1, recovering the solvent from the eluent under reduced pressure and evaporating to dryness, to obtain a crude extract of golden amide alcohol acetate; 3) Preparation of high-purity golden amide alcohol acetate: Take the above-mentioned golden amide alcohol acetate crude extract, dissolve it in petroleum ether, then add ethyl acetate dropwise, let it stand, and then precipitate a light yellow powder, which is then washed with petroleum ether to obtain a white powder with a purity greater than 98% of golden amide alcohol acetate.
2. The method for extracting and preparing high-purity golden amide alcohol acetate from the whole herb of Polygonum capitatum according to claim 1, characterized in that: In step 1), the extract is decompressed at a temperature not exceeding 65°C to recover the solvent; in step 2), the eluent is decompressed at a temperature not exceeding 65°C to recover the solvent.
3. The method for extracting and preparing high-purity golden amide alcohol acetate from the whole herb of Polygonum capitatum according to claim 1, characterized in that: In step 2), the column chromatography silica gel used is 100-200 mesh; the amount of silica gel used is 10 times the mass of the sample loaded on the column.
4. The method for extracting and preparing high-purity golden amide alcohol acetate from the whole herb of Polygonum capitatum according to claim 1, characterized in that: In step 3), the mass volume ratio of petroleum ether used for dissolution treatment to the crude extract of golden amide alcohol acetate is 1 mL:1 g; the volume ratio of ethyl acetate added before standing for precipitation to the petroleum ether used for dissolution treatment is 1:10; the volume ratio of petroleum ether used for washing treatment to the petroleum ether used for dissolution treatment is 1:
10.
5. Use of the golden amide alcohol acetate according to claim 1 in the preparation of the anti-gastric cancer BGC-823 drug.
Citation Information
Patent Citations
Communication device
US8121641B1
Method for separating and purifying active component aurantiamide acetate from traditional Chinese medicine clematis terniflora
CN102070485A
Wedelia trilobata anti-tumor extract and preparation and application methods thereof
CN107522680A
